MX339671B - Forma oral solida con perfil de liberacion dual que contiene particulas multiples. - Google Patents

Forma oral solida con perfil de liberacion dual que contiene particulas multiples.

Info

Publication number
MX339671B
MX339671B MX2010011409A MX2010011409A MX339671B MX 339671 B MX339671 B MX 339671B MX 2010011409 A MX2010011409 A MX 2010011409A MX 2010011409 A MX2010011409 A MX 2010011409A MX 339671 B MX339671 B MX 339671B
Authority
MX
Mexico
Prior art keywords
active agent
weight
polymer
release
release profile
Prior art date
Application number
MX2010011409A
Other languages
English (en)
Spanish (es)
Other versions
MX2010011409A (es
Inventor
Guimberteau Florence
Daviaud Anne-Sophie
Original Assignee
Flamel Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flamel Ireland Ltd filed Critical Flamel Ireland Ltd
Publication of MX2010011409A publication Critical patent/MX2010011409A/es
Publication of MX339671B publication Critical patent/MX339671B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
MX2010011409A 2008-04-18 2009-04-17 Forma oral solida con perfil de liberacion dual que contiene particulas multiples. MX339671B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7125008P 2008-04-18 2008-04-18
FR0852627A FR2930147B1 (fr) 2008-04-18 2008-04-18 Forme orale solide dotee d'un double profil de liberation
PCT/FR2009/050719 WO2009138642A1 (fr) 2008-04-18 2009-04-17 Forme orale solide dotee d'un double profil de liberation comprenant des multiparticules

Publications (2)

Publication Number Publication Date
MX2010011409A MX2010011409A (es) 2010-12-02
MX339671B true MX339671B (es) 2016-06-03

Family

ID=40110982

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010011409A MX339671B (es) 2008-04-18 2009-04-17 Forma oral solida con perfil de liberacion dual que contiene particulas multiples.

Country Status (14)

Country Link
US (1) US20090291137A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP2276474B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP5687185B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR101380507B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN102046155A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU2009247921B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BRPI0910572B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2721232C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2721849T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2930147B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL208572A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX339671B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2009138642A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA201007238B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2945947B1 (fr) 2009-05-29 2011-07-29 Flamel Tech Sa Compositions pharmaceutiques flottantes a liberation controlee
WO2013156163A1 (en) 2012-04-19 2013-10-24 Glatt Ag Taste-masked pharmaceutical compositions containing diclofenac
WO2016053835A1 (en) * 2014-09-30 2016-04-07 Dow Global Technologies Llc Aqueous ethylcellulose dispersions with polymeric additive
CA2978593A1 (en) 2015-01-12 2016-07-21 Nano Pharmaceutical Laboratories Llc Layered sustained-release microbeads and methods of making the same
JP6112696B1 (ja) * 2015-10-05 2017-04-12 富山化学工業株式会社 ソリスロマイシンを含む錠剤
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
FR3089406B1 (fr) 2018-12-07 2020-11-20 Urgo Rech Innovation Et Developpement Dispositif de retenue et système de contention comprenant un article de contention et un tel dispositif de retenue
FR3089405A1 (fr) 2018-12-07 2020-06-12 Urgo Recherche Innovation Et Developpement Dispositif de retenue et système de contention comprenant un article de contention et un tel dispositif de retenue
CA3138100A1 (en) 2019-04-17 2020-10-22 Compass Pathfinder Limited Treatment of depression and other various disorders with psilocybin
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE66933B1 (en) * 1990-01-15 1996-02-07 Elan Corp Plc Controlled absorption naproxen formulation for once-daily administration
NZ253999A (en) * 1992-08-05 1996-07-26 Faulding F H & Co Ltd Pelletised substained release medicament
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
US5458888A (en) * 1994-03-02 1995-10-17 Andrx Pharmaceuticals, Inc. Controlled release tablet formulation
JPH0826977A (ja) * 1994-07-19 1996-01-30 Tanabe Seiyaku Co Ltd 溶出制御型経口製剤
TW580397B (en) * 1997-05-27 2004-03-21 Takeda Chemical Industries Ltd Solid preparation
US8545880B2 (en) * 1999-02-26 2013-10-01 Andrx Pharmaceuticals, Llc Controlled release oral dosage form
US6627223B2 (en) * 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
US6991807B2 (en) * 2000-02-24 2006-01-31 Advancis Pharmaceutical, Corp. Antibiotic composition
US7223421B2 (en) * 2000-06-30 2007-05-29 Mcneil-Ppc, Inc. Teste masked pharmaceutical particles
US6500457B1 (en) * 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
EP1258241A1 (en) * 2001-05-16 2002-11-20 BIOPROGRESS S.p.A. Method of increasing the bioavailability of nimesulide
FR2830447B1 (fr) * 2001-10-09 2004-04-16 Flamel Tech Sa Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
US7939102B2 (en) * 2002-06-07 2011-05-10 Torrent Pharmaceuticals Ltd. Controlled release formulation of lamotrigine
US7294347B2 (en) * 2004-06-21 2007-11-13 Council Of Scientific And Industrial Research Coating compositions for bitterness inhibition
US20060263429A1 (en) * 2005-05-20 2006-11-23 Hengsheng Feng Compressible mixture, compressed pharmaceutical compositions, and method of preparation thereof
KR20070021806A (ko) * 2005-08-19 2007-02-23 (주)아모레퍼시픽 α1-수용체 차단제의 서방형 펠렛제제 및 이의 제조 방법
GB0517205D0 (en) * 2005-08-22 2005-09-28 Novartis Ag Organic compounds
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
BRPI0716196A2 (pt) * 2006-08-31 2013-11-12 Eurand Inc Sistemas de distribuição de fármacos que compreendem soluções sólidas de fármacos fracamente básicos.

Also Published As

Publication number Publication date
EP2276474B1 (fr) 2019-03-06
CN102046155A (zh) 2011-05-04
FR2930147B1 (fr) 2013-02-08
AU2009247921A1 (en) 2009-11-19
KR101380507B1 (ko) 2014-04-11
BRPI0910572B1 (pt) 2021-10-13
MX2010011409A (es) 2010-12-02
CA2721232A1 (fr) 2009-11-19
FR2930147A1 (fr) 2009-10-23
IL208572A0 (en) 2010-12-30
KR20110005876A (ko) 2011-01-19
US20090291137A1 (en) 2009-11-26
BRPI0910572A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2017-08-08
AU2009247921B2 (en) 2013-09-05
JP5687185B2 (ja) 2015-03-18
CA2721232C (fr) 2016-03-29
ZA201007238B (en) 2011-06-29
EP2276474A1 (fr) 2011-01-26
JP2011518139A (ja) 2011-06-23
IL208572A (en) 2016-02-29
WO2009138642A1 (fr) 2009-11-19
ES2721849T3 (es) 2019-08-05

Similar Documents

Publication Publication Date Title
MX339671B (es) Forma oral solida con perfil de liberacion dual que contiene particulas multiples.
WO2010049433A3 (en) Water insoluble polymer: starch-based film coatings for colon targeting
NZ778023A (en) Colonic drug delivery formulation
MX2012004472A (es) Forma farmaceutica oral solida contra el uso indebido y que tiene un perfil especifico de liberacion modificada.
WO2010037054A3 (en) Heteroaryl antagonists of prostaglandin d2 receptors
WO2010039977A3 (en) Heteroaryl antagonists of prostaglandin d2 receptors
WO2010003120A3 (en) Antagonists of prostaglandin d2 receptors
WO2011106416A3 (en) Abuse-resistant formulations
WO2009108720A3 (en) Antagonists of prostaglandin d2 receptors
WO2009140642A3 (en) Tricyclic antagonists of prostaglandin d2 receptors
GB0617480D0 (en) Novel nanoparticles
WO2011084593A3 (en) Abuse-resistant formulations
WO2010125323A8 (en) Biocidal composition
WO2010077882A3 (en) Antagonists of lysophosphatidic acid receptors
MX360389B (es) Formulacion farmaceutica o nutraceutica resistente a fluidos gastricos que comprende una o mas sales de acido alginico.
WO2008156509A3 (en) Cationic latex as a carrier for bioactive ingredients and methods for making and using the same
WO2009034541A3 (en) Controlled release pharmaceutical dosage forms of trimetazidine
WO2009145989A3 (en) Aminoalkylphenyl antagonists of prostaglandin d2 receptors
WO2010057118A3 (en) Heterocyclic antagonists of prostaglandin d2 receptors
WO2010042652A3 (en) Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
WO2009129311A3 (en) Somatostatin receptor 2 antagonists
MX2011006578A (es) Formulaciones farmaceuticas de liberacion prolongada.
WO2008064163A3 (en) Polymer coated drug-ion exchange resins and methods
MX2011009669A (es) Composición farmacéutica de liberación controlada con resistencia a la influencia de etanol mediante un revestimiento compuesto de una mezcla polimérica y excipientes.
WO2009111643A3 (en) Microrna markers for recurrence of colorectal cancer

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: FLAMEL IRELAND LIMITED

FG Grant or registration